92711-55-2

Basic information

• Product Name: 9-oxo-15-hydroxy-delta 7,10,13-prostatrienoic acid methyl ester
• Synonyms: 9-oxo-15-hydroxy-delta 7,10,13-prostatrienoic acid methyl ester
• CAS NO: 92711-55-2
• Molecular Formula: C₂₁H₃₂O₄
• Molecular Weight: 348.47638
• Mol File: 92711-55-2.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 484.3°Cat760mmHg
• Flash Point: 160.8°C
• Appearance: /
• Density: 1.107g/cm³
• Vapor Pressure: 2.06E-11mmHg at 25°C
• Refractive Index: 1.573
• CAS DataBase Reference: 9-oxo-15-hydroxy-delta 7,10,13-prostatrienoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 9-oxo-15-hydroxy-delta 7,10,13-prostatrienoic acid methyl ester(92711-55-2)
• EPA Substance Registry System: 9-oxo-15-hydroxy-delta 7,10,13-prostatrienoic acid methyl ester(92711-55-2)

Safety Data

• Hazardous Substances Data: 92711-55-2(Hazardous Substances Data)

Usage

InChI:InChI=1/C21H32O4/c1-3-4-7-10-18(22)15-13-17-14-16-20(23)19(17)11-8-5-6-9-12-21(24)25-2/h11,13-18,22H,3-10,12H2,1-2H3/b15-13+,19-11+/t17-,18-/m0/s1

Upstream product

• 188253-83-0 7-[(2R,3R)-2-((E)-(S)-3-Hydroxy-oct-1-enyl)-3-methylsulfanyl-5-oxo-cyclopent-(E)-ylidene]-heptanoic acid methyl ester 

Relevant articles and documents

Chemical implications for antitumor and antiviral prostaglandins: Reaction of Δ7-prostaglandin A1 and prostaglandin A1 methyl esters with thiols

Prostaglandins (PGs) such as Δ12-PGJ2 and Δ7-PGA1 methyl ester that possess a cross-conjugated dienone unit exhibit unique antitumor and antiviral activities independent of intracellular cAMP levels. These compounds are transported reversibly into cultured cells and accumulate in nuclei via covalent interaction, eliciting growth inhibition. PGA1 methyl ester, a simple cyclopentenone analog, is less potent. The unique cellular behavior of the dienone PGs correlates well with their chemical properties. The PGs react specifically with thiol nucleophiles such as glutathione. Michael addition of thiols to Δ7-PGA1 methyl ester, an alkylidenecyclopentenone derivative, occurs facilely at the endocyclic C(11) position rather than at the C(7) position. This process is reversible, and in solution phase, the adducts are in equilibrium with considerable amounts of free PG and thiols. However, the reaction of this PG with Sepharose-bound thiols, regarded to be plausible mimics of protein thiols, is irreversible, and the resulting adducts are dissociated only by alkali treatment. On the other hand, PGA1 methyl ester reacts with soluble or polymer-anchored thiols at lower rates than Δ7-PGA1 methyl ester, but the resulting thiol adducts are substantially more stable than those of the dienone PGs. This tendency of the PGA1 methyl ester causes its equilibrium to shift to the adduct formation. The reversibility of the Michael reaction of PGs with thiols is consistent with their intracellular behavior and biological activities. Since glutathione adducts of PGs have no antiproliferative activities for cancer cells, the intracellular free PGs are presumed to interact with target molecules to cause cell growth inhibition. The involvement of the ATP-dependent glutathione S-conjugate export pump (GS-X pump) in the efflux of PGs is discussed. Thus, the marked difference in potency of the dienone and enone PGs is explained by considering the combined kinetic and thermodynamic properties and the action of the GS-X pump.